Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?

Hepato-Gastroenterology

Volumn 54, Issue 74, 2007, Pages 359-363

  Svoboda, Petr ^a,d   Kantorová, Ilona ^a   Scheer, Peter ^b   Radvanova, Jana ^c   Radvan, Martin ^c  

^a Traumatological Hospital of Brno   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c Hospital Trebic   (Czech Republic)

^d NONE   (Czech Republic)

Author keywords

Antibiotics; Microbiology; Re intervention; Severe sepsis

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ABDOMINAL SURGERY; ADULT; AGED; AIR CONDITIONING; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERVENTION STUDY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MORTALITY; MULTIPLE TRAUMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPSIS; SINGLE BLIND PROCEDURE; SURGEON;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN; CROSS INFECTION; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; INJURY SEVERITY SCORE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; REOPERATION; RESPIRATION, ARTIFICIAL; SEPSIS;

EID: 34248172813     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sands KE, Bates DW, Lanken PN, et al: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997; 278:234-240.
2. Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 2001; 29(Suppl):S109-116.
3. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
4. Guillemot D, Courvalin P, et al: Better control of antibiotic resistance. Clin Infect Dis 2001; 33:542-547.
5. Schito GC, Debbia EA, Marchese A: The evolving threat of antibiotic resistance in Europe: new data from the Alexander project. J Antimicrob Chemother 200; 46(Suppl TI):3-9.
6. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as marker of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39:206-217.
7. Bell K, Wattie M, Byth K, et al: Procalcitonin: a marker of bacteraemia in SIRS. Anaesth Intensive Care 2003; 31:629-636.
8. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27:498-504.
9. Müller B, Becker KL, Schachinger H et al: Calcitonin precursors are reliable markers of sepsis in the intensive care unit. Crit Care Med 2000; 28:977-983.
10. Meisner M, Tschaikowski K, Schmidt J, Schuttler J: Procalcitonin (PCT) - Indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovasc Eng 1996; 1:67-76.
11. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363:600-607.
12. Soderquist B, Jones I, Fredlund H, et al: Bacterial or crystal-associated arthritis? Discrimination ability of serum inflammatory markers. Scand J Infect Dis 1998; 30:591-596.
13. Wanner GA, Keel M, Steckholzer U, et al: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000; 28:950-957.
14. Meisner M, Tschaikowski K, Hutzler A, Schick C, Schuttler J: Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24:680-684.
15. Stiletto RJ, Baacke M, Gotzen L, Lefering R, Renz H: Procalcitonin versus interleukin-6 levels in bronchoalveolar lavage fluids of trauma victims with severe lung contusion. Crit Care Med 2001; 29:1690-1693.
16. Petrikkos GL, Chritofilopoulou SA, Tentolouris NK, et al: Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis 2005; 24:272-275.
17. Delevaux I, Andre M, Colombier M, et al: Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62:337-340.
18. Arkader R, Troster EJ, Lopes MR, et al: Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 2005 Dec 2; Epub ahead of print.
19. Christ-Crain M, Müller B: Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med wkly 2005; 135:451-460.
20. Balci C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B: Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7:85-90.
21. Persson L, Soderquist B, Engervall P, et al: Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 2005; 74:297-303.
22. Meisner M: Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005; 11:473-480.
23. Axer H, Wohlfarth M, Meisner M, et al: Procalcitonin as a marker for severe sepsis in an immunosuppressed patient. Anasthesiol Intensivmed Notfallmed Schmerzther 2005; 40:97-102.
24. Bell K, Wattie M, Silvestrini R, et al: Procalcitonin: a marker of bacteremia in SIRS. Anaesth Intensive Care 2003; 31:629-636.
25. Bone RC, Balk RA, Cerra FB, et al: Definition for sepsis and organ failure and guidelines for the use of inovative therapies in sepsis. The ACCP-SCCM Consensus Conference on sepsis and organ failure. Chest 1992; 101:1644-1655.
26. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22(7):707-710.
27. Emmanuel K, Weighardt H, Bartels H, Siewert JR, Holzmann B: Current and future concepts of abdominal sepsis. World J Surg 2005; 29:3-9.
28. Kieft H, Hoepelman AI, Zhou W, et al: The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med 1993; 153:2241-2247.
29. Aikawa N, Fujishima S, Endo S, et al: Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005; 11(3):152-159.
30. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL: Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005; 146:347-351.
31. Meisner M, Brunkhorst FM, Reith HB, et al: Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin. Clin Chem Lab Med 2000; 38:989-995.